| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Dr. Jagust), University of California, Davis; Departments of Health Studies and Statistics (Dr. Thisted), University of Chicago, IL; Department of Radiology (Dr. Devous), University of Texas Southwestern Medical Center, Dallas; Department of Radiology (Dr. Van Heertum), Columbia University, New York; Rotman Research Institute (Dr. Mayberg), University of Toronto, Ontario, Canada; Oxford Project to Investigate Memory in Aging (OPTIMA) (Drs. Jobst and Smith), Department of Pharmacology, University of Oxford, UK; and Cytogen Corporation (Dr. Borys), Princeton, NJ.
Address correspondence and reprint requests to Dr. William Jagust, Department of Neurology, University of California Davis Medical Center, 4860 Y Street, Suite 3700, Sacramento, CA 95817.
OBJECTIVE: Numerous studies have suggested that temporoparietal hypoperfusion seen on brain imaging with SPECT may be useful in diagnosing AD during life. However, these studies have often been limited by lack of pathologic validation and unrepresentative samples. The authors performed this study to determine whether SPECT imaging provides diagnostically useful information in addition to that obtained from a clinical examination.
METHODS: Clinical data and SPECT images were collected prospectively, and patients were followed to autopsy. Clinical history, pathologic findings, and SPECT images were each evaluated by raters blind to other features, and clinical and SPECT diagnoses were compared with pathologic diagnoses. The study population consisted of 70 patients with dementia, followed to autopsy; 14 controls followed to autopsy; and 71 controls (no autopsy performed). The primary outcome was the likelihood of a pathologic diagnosis of AD given a positive clinical diagnosis, a positive SPECT diagnosis, and both.
RESULTS: When all participants (patients and controls) were included in the analysis, the clinical diagnosis of "probable" AD was associated with an 84% likelihood of pathologic AD. A positive SPECT scan raised the likelihood of AD to 92%, whereas a negative SPECT scan lowered the likelihood to 70%. SPECT was more useful when the clinical diagnosis was "possible" AD, with the likelihood of 67% without SPECT, 84% with a positive SPECT, and 52% with a negative SPECT. Similar results were found when only patients with dementia were included in the analysis.
CONCLUSIONS: In the evaluation of dementia, SPECT imaging can provide clinically useful information indicating the presence of AD in addition to the information that is obtained from clinical evaluation.
This article has been cited by other articles:
|
|
 |
|
  J T O'BRIEN Role of imaging techniques in the diagnosis of dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S71 - S77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jagust, B. Reed, D. Mungas, W. Ellis, and C. DeCarli What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology, August 28, 2007; 69(9): 871 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A D MURRAY Imaging in dementia Imaging, June 1, 2007; 19(2): 133 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R McNeill, G M Sare, M Manoharan, H J Testa, D M A Mann, D Neary, J S Snowden, and A R Varma Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 350 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Dougall, S. Bruggink, and K. P. Ebmeier Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia Am J Geriatr Psychiatry, December 1, 2004; 12(6): 554 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H.S. Silverman Brain 18F-FDG PET in the Diagnosis of Neurodegenerative Dementias: Comparison with Perfusion SPECT and with Clinical Evaluations Lacking Nuclear Imaging J. Nucl. Med., April 1, 2004; 45(4): 594 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Norfray and J. M. Provenzale Alzheimer's Disease: Neuropathologic Findings and Recent Advances in Imaging Am. J. Roentgenol., January 1, 2004; 182(1): 3 - 13. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Friedenberg Dementia: One of the Greatest Fears of Aging Radiology, December 1, 2003; 229(3): 632 - 635. [Full Text] [PDF]
|
|
|
|
|
|
G B Frisoni, P h Scheltens, S Galluzzi, F M Nobili, N C Fox, P H Robert, H Soininen, L-O Wahlund, G Waldemar, and E Salmon Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1371 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Clark and J. H.T. Karlawish Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies Ann Intern Med, March 4, 2003; 138(5): 400 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Petrella, R. E. Coleman, and P. M. Doraiswamy Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future Radiology, February 1, 2003; 226(2): 315 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Neugroschl and K. L. Davis Biological Markers in Alzheimer Disease Am J Geriatr Psychiatry, December 1, 2002; 10(6): 660 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Nobili, M. Koulibaly, P. Vitali, O. Migneco, G. Mariani, K. Ebmeier, A. Pupi, P. H. Robert, G. Rodriguez, and J. Darcourt Brain Perfusion Follow-Up in Alzheimer's Patients During Treatment with Acetylcholinesterase Inhibitors J. Nucl. Med., August 1, 2002; 43(8): 983 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Bradley, V. T. O'Sullivan, N. D. W. Soper, Z. Nagy, E. M.-F. King, A. D. Smith, and B. J. Shepstone Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease Brain, August 1, 2002; 125(8): 1772 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Van Laere, J. Warwick, J. Versijpt, I. Goethals, K. Audenaert, B. Van Heerden, and R. Dierckx Analysis of Clinical Brain SPECT Data Based on Anatomic Standardization and Reference to Normal Data: An ROC-Based Comparison of Visual, Semiquantitative, and Voxel-Based Methods J. Nucl. Med., April 1, 2002; 43(4): 458 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Other articles noted Evid. Based Ment. Health, November 1, 2001; 4(4): 104 - 104. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
